Antiepileptic drugs: Energy-consuming processes governing drug disposition.
نویسندگان
چکیده
Diffusion is not the main process by which drugs are disposed throughout the body. Translational movements of solutes given by different energy-consuming mechanisms are required in order to dispose them efficiently. Membrane transportation and cardiac output distribution are two effective processes to move the molecules among different body sites. Gastrointestinal-blood cycling constitutes a supplementary way to regulate the distribution of molecules between the non-hepatic organs and the liver. Any change in the relative supply of drug molecules among eliminating organs could modify their clearance from the body. Either the nonlinear phenytoin (PHT) pharmacokinetic response or the influence that carbamazepine (CBZ) exerts on PHT exposure could be explained throughout their efflux transporter inducer abilities. Cardiac output distribution difference between the individuals might also explain the dual CBZ-over-PHT interaction response. Finally, valproic acid (VPA) pharmacokinetics can be understood by adding to these mechanisms of transportation its ability to cross the mitochondrial membrane of the hepatocyte.
منابع مشابه
[Frontiers in Bioscience E6, 387-396, June 1, 2014] Antiepileptic drugs: Energy-consuming processes governing drug disposition
1. Abstract 2. Basic principle for corporal drug movement 2.1. Membrane transporters 2.2. Cardiac output distribution 2.3. Gastrointestinal-blood cycling 2.4. Drug distribution throughout the splanchnic organs 2.5. Efflux transportation, blood flow fraction, and drug recycling 3. Phenytoin 3.1. Michaelis-Menten consideration 3.2. Hepatic, intestinal, and renal contribution to phenytoin clearanc...
متن کاملThe multidrug transporter P-glycoprotein in pharmacoresistance to antiepileptic drugs.
This review provides an overview of the knowledge on P-glycoprotein (P-gp) and its role as a membrane transporter in drug resistance in epilepsy and drug interactions. Overexpression of P-gp, encoded by the ABCB1 gene, is involved in resistance to antiepileptic drugs (AEDs), limits gastrointestinal absorption and brain access of AEDs. Although several association studies on ABCB1 gene with drug...
متن کاملClinical pharmacology of parenteral use of antiepileptic drugs.
Intravenous (i.v.) administration of antiepileptic drugs (AEDs) produces the most rapid onset of action, as it is delivered directly into the bloodstream and immediately produces maximal plasma concentration (C0 = Cmax). In addition to its therapeutic value, i.v. administration is essential in investigating the pharmacokinetics (PK) or clinical pharmacology of drugs, as it bypasses absorption a...
متن کاملChallenges in the Treatment of Epilepsy
Epilepsy is one of the most important diseases of nervous system that involves 0.5-1% of the population. In spite of new developments in antiepileptic drugs, between 20-30% of epileptic patients can not be controlled and even those who are controlled with antiepileptic drugs suffer from their adverse events. Epileptic patients have different challenges in relation to the disease and its medicat...
متن کاملClinical pharmacokinetics of antiepileptic drugs in adults.
Over the past 15 years, thanks to the development of clinical pharmacology, pharmacokinetics and more accurate analytical techniques, many of the variables determining the effects of drugs have been better defined and understood. We know today that the effects of most therapeutic agents are related on the one hand to the functional status of the receptors and on the other to the concentration o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Frontiers in bioscience
دوره 6 شماره
صفحات -
تاریخ انتشار 2014